Posts

Optimal Sleep May Lower Dementia Risk in Focal Epilepsy

Optimal sleep duration is tied to better cognition and a lower risk for dementia in adults with focal epilepsy than in healthy individuals, new research shows. Medscape Medical News source https://www.medscape.com/viewarticle/optimal-sleep-may-lower-dementia-risk-focal-epilepsy-2026a1000fjr?src=rss

How Bariatric Surgery Shapes IBD Risk Over Time in Obesity

In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease within 3 years but a higher risk over longer follow-up. Medscape Medical News source https://www.medscape.com/viewarticle/how-bariatric-surgery-shapes-ibd-risk-over-time-obesity-2026a1000fjj?src=rss

Telerehabilitation May Support Stroke Recovery at Home

Remote rehabilitation programs improve mobility, balance, and quality of life after stroke, with added benefits in adherence and patient satisfaction. Medscape News Europe source https://www.medscape.com/viewarticle/telerehabilitation-may-support-stroke-recovery-home-2026a1000fe9?src=rss

Can Gut Bacterium Supplement Lead to Less Weight Regain?

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity. Medscape Medical News source https://www.medscape.com/viewarticle/can-gut-bacterium-supplement-lead-less-weight-regain-2026a1000fdy?src=rss

Sigmoidoscopy Cuts Colorectal Cancer Risk in Men

Researchers randomly assign more than 100,000 adults without CRC to receive once-only sigmoidoscopy screening or no screening between 1999 and 2001. Here’s what they find. Medscape Medical News source https://www.medscape.com/viewarticle/sigmoidoscopy-cuts-colorectal-cancer-risk-men-2026a1000f7b?src=rss

Combo Therapy Boosts Early CML Response but Not Long Term

A phase 3 trial evaluates the efficacy and safety of nilotinib with pegylated interferon alfa-2a in patients with newly diagnosed chronic-phase chronic myeloid leukemia. Medscape Medical News source https://www.medscape.com/viewarticle/combo-therapy-boosts-early-cml-response-not-long-term-2026a1000f6z?src=rss